Clinical Trials Browser

Withdrawn × INDUSTRY × sabizabulin × Clear all

NCT05079360 2023-03-24

Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms

NCT05008510 2022-02-08

VERU-111

Phase 2 Withdrawn

Triple Negative Breast Neoplasms